Pacira BioSciences, Inc. (PCRX) — Long-term Investment Intensity
Pacira BioSciences, Inc. (PCRX) has a Long-term Investment Intensity of 1.6% as of September 2025. Long-term investments of $20.27 Million represent 1.6% of total assets of $1.30 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Pacira BioSciences, Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Pacira BioSciences, Inc. Long-term Investment Intensity (2014–2023)
This chart shows how Pacira BioSciences, Inc.'s Long-term Investment Intensity has evolved across 9 annual periods from 2014 to 2023. As of September 2025, the intensity stands at 1.6%, reflecting long-term investments of $20.27 Million against total assets of $1.30 Billion USD. Explore cash flow to debt ratio of Pacira BioSciences, Inc. to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Pacira BioSciences, Inc. (2014–2023)
The table below presents the year-by-year Long-term Investment Intensity for Pacira BioSciences, Inc. from 2014 to 2023, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see PCRX market cap overview.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.2% | $2.41 Million | $1.57 Billion | ▼ -3.7 pp |
| 2022 | 3.8% | $64.38 Million | $1.68 Billion | ▲ +2.8 pp |
| 2021 | 1.1% | $21.99 Million | $2.08 Billion | ▼ -7.5 pp |
| 2020 | 8.6% | $109.48 Million | $1.27 Billion | ▲ +0.8 pp |
| 2019 | 7.8% | $64.80 Million | $831.07 Million | ▲ +4.0 pp |
| 2018 | 3.8% | $25.87 Million | $689.35 Million | ▼ -5.8 pp |
| 2017 | 9.6% | $60.05 Million | $628.37 Million | ▲ +6.1 pp |
| 2015 | 3.5% | $13.46 Million | $389.62 Million | ▼ -4.0 pp |
| 2014 | 7.5% | $24.43 Million | $326.07 Million | — |